START "THE CURE STARTS HERE"

Welcome to the Brand page for “START "THE CURE STARTS HERE"”, which is offered here for The mark consists of the stylized word start wherein the letter a is formed by a green helix design and the remaining letters are blue. the green stylized wording the cure starts here. is presented below start, under which a green x design depicting the bottom of the helix appears.;the color(s) blue and green is/are claimed as a feature of the mark.;medical services, cancer diagnosis, therapy, prevention, and treatment; providing healthcare information in the field of cancer prevention, screening, diagnosis and treatment;medical and scientific research, conducting clinical trials for others; medical and scientific research services in the field of cancer diagnosis, therapy, prevention, and treatment, and conducting clinical trials for others in the field of cancer diagnosis, therapy, prevention, and treatment; pharmaceutical drug development services; structural and functional analysis of genomes;.

Its status is currently believed to be active. Its class is unavailable. “START "THE CURE STARTS HERE"” is believed to be currently owned by “SOUTH TEXAS ACCELERATED RESEARCH THERAPEUTICS, LLC”.

Owner:
SOUTH TEXAS ACCELERATED RESEARCH THERAPEUTICS, LLC
Owner Details
Description:
The mark consists of the stylized word START wherein the letter A is formed by a green helix design and the remaining letters are blue. The green stylized wording THE CURE STARTS HERE. is presented below START, under which a green X design depicting the bottom of the helix appears.;The color(s) blue and green is/are claimed as a feature of the mark.;Medical services, cancer diagnosis, therapy, prevention, and treatment; Providing healthcare information in the field of cancer prevention, screening, diagnosis and treatment;Medical and scientific research, conducting clinical trials for others; Medical and scientific research services in the field of cancer diagnosis, therapy, prevention, and treatment, and conducting clinical trials for others in the field of cancer diagnosis, therapy, prevention, and treatment; Pharmaceutical drug development services; Structural and functional analysis of genomes;
Categories: